back to Meetings page
  • IMMPACT-IV
  • June 11-12, 2004
  • Willard InterContinental Hotel
  • Washington, DC

  • Co-chairs:
  • Dennis C. Turk, PhD (University of Washington)
  • Robert H. Dworkin, PhD (University of Rochester)
  • Academia Participants
  • Dorcas Beaton, PhD (Institute for Work & Health, Toronto)
  • David Cella, PhD (Northwestern University)
  • Charles S. Cleeland, PhD (MD Anderson Cancer Center)
  • John T. Farrar, MD (University of Pennsylvania)
  • Jennifer Haythornthwaite, PhD (Johns Hopkins University)
  • Alejandro R. Jadad, MD, DPhil (University of Toronto)
  • Mark P. Jensen, PhD (University of Washington)
  • Nathaniel P. Katz, MD (Newton, MA)
  • Henrik Kehlet, MD, PhD (Hvidovre University Hospital, Denmark)
  • Robert D. Kerns, PhD (Yale University)
  • Cynthia McCormick, MD (McCormick Consultation)
  • Michael McDermott, PhD (University of Rochester)
  • Henry J McQuay, MD (University of Oxford)
  • Dennis A. Revicki, PhD (MEDTAP International)
  • Kenneth E. Schmader, MD (Duke University)
  • Brett R. Stacey, MD (University of Oregon)
  • Kathleen W. Wyrwich, PhD (Saint Louis University)
  • Government Participants
  • Deborah N. Ader, PhD (US National Institute of Health)
  • Laurie B. Burke, RPh, MPH (US Food and Drug Administration)
  • Raymond Dionne, DDS, PhD (US National Institute of Health)
  • Sharon Hertz, MD (US Food and Drug Administration)
  • Linda Porter, PhD (US National Institute of Health)
  • Bob A. Rappaport, MD (US Food and Drug Administration)
  • James Witter, MD, PhD (US Food and Drug Administration)
  • Patient Representative
  • Penney Cowan (American Chronic Pain Asssociation)
  • Industry Participants
  • Nancy Brandenburg, PhD (Pfizer)
  • Julie Chandler, PhD (Merck & Company)
  • Rozalina Dimitrova, MD, MPH (Allergan, Inc.)
  • Lynn D. Kramer, MD (Purdue Pharma)
  • Donald C. Manning, MD, PhD (Celgene Corporation)
  • Sanjay Patel, PhD (Elan Pharmaceuticals)
  • Steven Quessy, PhD (GlaxoSmithKline)
  • Christine Rauschkolb, MD, PhD (Schwarz Biosciences GmbH)
  • Margaret Rothman, PhD (Johnson & Johnson)
  • Joseph W. Stauffer, DO (Alpharma)
  • Thorsten von Stein, MD, PhD (NeurogesX, Inc.)
  • Richard E. White, PhD (Endo Pharmaceuticals)
  • Stojan Zavisic, BSc (AstraZeneca Pharmaceuticals)